Duracrin, LLC

Biotechnology company · New Haven, Connecticut, United States

Duracrin, LLC is a biotechnology company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Duracrin at a glance

Typebiotechnology company

HeadquartersNew Haven, Connecticut, United States

Earliest incorporation on record2025

SEC CIK2113010

What does Duracrin do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1 million sold (2026).

Frequently asked questions about Duracrin

Where is Duracrin headquartered?

Duracrin, LLC is headquartered in New Haven, Connecticut, United States.

What does Duracrin do?

Duracrin, LLC is a biotechnology company.

When was Duracrin founded?

The earliest incorporation on record for Duracrin, LLC is in 2025, according to public company registers.

Similar companies

Allyx Therapeutics, Inc.New Haven, Connecticut, United States
Invivyd, Inc.New Haven, Connecticut, United States
ReNetX Bio, Inc.New Haven, Connecticut, United States
AtlasXomics Inc.New Haven, Connecticut, United States
Vion Pharmaceuticals IncNew Haven, Connecticut, United States
ProteoWise Inc.New Haven, Connecticut, United States
Oui Therapeutics IncNew Haven, Connecticut, United States
Modifi Biosciences, Inc.New Haven, Connecticut, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences